Advancing mental health treatments. Multiple Phase 2B clinical trials underway. Publicly listed on CSE:MBIO FRA:WF6.
MindBio Therapeutics is at the forefront of pharmaceutical manufacturing, dedicated to advancing mental health treatments through innovative clinical trials. With multiple Phase 2B clinical trials underway, MindBio Therapeutics is committed to pioneering solutions for critical mental health challenges.
Located at 91-97 William Street, Level 4, Melbourne, Victoria 3000, AU, MindBio Therapeutics focuses on developing and delivering cutting-edge treatments. The company is publicly listed on CSE:MBIO FRA:WF6, reflecting its commitment to transparency and growth. MindBio Therapeutics is dedicated to improving patient outcomes and transforming mental healthcare.
MindBio Therapeutics continues to innovate and expand its reach within the pharmaceutical industry. We invite the management team at MindBio Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their advancements and capabilities.
MindBio Therapeutics est à l'avant-garde de la fabrication pharmaceutique, se consacrant à faire progresser les traitements de santé mentale grâce à des essais cliniques innovants. Avec de multiples essais cliniques de phase 2B en cours, MindBio Therapeutics s'engage à trouver des solutions aux défis cruciaux en matière de santé mentale.
Située au 91-97 William Street, Level 4, Melbourne, Victoria 3000, AU, MindBio Therapeutics se concentre sur le développement et la fourniture de traitements de pointe. La société est cotée en bourse sur CSE:MBIO FRA:WF6, ce qui témoigne de son engagement envers la transparence et la croissance. MindBio Therapeutics se consacre à l'amélioration des résultats pour les patients et à la transformation des soins de santé mentale.
MindBio Therapeutics continue d'innover et d'étendre sa portée au sein de l'industrie pharmaceutique. Nous invitons l'équipe de direction de MindBio Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur leurs avancées et leurs capacités.
Compare MindBio Therapeutics with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
MindBio TherapeuticsMain Company |
Drug Discovery & Dev...View Profile |
MassDeviceView Profile |
BioXcel Therapeutics...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2009 | 2017 |
|
Company Size
|
— | 51-200 | 51-200 | 51-200 |
|
City
|
Melbourne , Victoria | Cleveland, Ohio | Cleveland, Ohio | New Haven, Connecticut |
|
Country
|
Australia | United States | United States | United States |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Pharmaceutical Manufacturing
Mental Health Treatments
Clinical Trials
Psychedelic Microdosing
Drug Development
Mental Healthcare
MB22001
Psychedelics
Wearables
Device Development
Drug Formulation
Artificial Intelligence
|
45 Total
1 Common
44 Unique
Match
8%
Common Skills:
Drug Development
Unique Skills:
Big Pharma
BioPharma
Biopharmaceuticals
BioTech
Biotechnology
Contract Research Organizations
+38
|
51 Total
51 Unique
Unique Skills:
Academic Researchers
Device Manufacturing
Diagnostics
Digital Health
Engineers
Entrepreneurs
+45
|
10 Total
10 Unique
Unique Skills:
Big Data
Clinical Pharmacology
Clinical Research
Drug Discovery
Immuno-oncology
Innovative Medicine
+4
|
Other organizations in the same industry
This company is also known as